Novo Nordisk AS (NYSE: NVO) posted better than expected results for the fiscal year. Shares were up over 8 percent after open on Thursday.The pharmaceutical company reported an 8 percent in operating profits in the first six months of the 2017...

Esperion Therapeutics Inc (NASDAQ: ESPR) announced positive top-level results for Phase 2 of trials for triplet oral therapy with bempedoic acid, ezetimibe and atorvastatin.The trials, which lasted six weeks, have yilded positive data as the LDL-C l..

On Tuesday, Valeant Pharmaceuticals Intl Inc (NYSE: VRX) announced its financial results for the second quarter. With earnings beating estimates, shares of the company increased 7.6% to $16.54 per share in morning trading on Tuesday after the announ..

On Friday, billionaire investor William Ackman announced that he will be buying a large stake in Automatic Data Processing Inc.(NASDAQ:ADP),  a move that made the U.S. payroll company’s stock increase 16.5% to $120.In recent years, activi..

AstraZeneca plc (NYSE: AZN) released a bevy of news today, including Q2 results, as well as study results for two drugs. AZN price has plummeted 15%.Following the loss of exclusivity for Crestor and Seroquel XR AstraZeneca had expected losses in the..